LOS ANGELES, CA - June 17, 2026 (NEWMEDIAWIRE) - A single heart attack or major cardiovascular event can have consequences that extend far beyond a patient’s health, affecting employers, insurers and healthcare systems through higher medical costs, lost productivity and long-term care expenses. As cardiovascular disease continues to drive a significant share of healthcare spending, organizations responsible for employee benefits are seeking new strategies to identify risk earlier and improve outcomes. Cardio Diagnostics Holdings (NASDAQ: CDIO) is engaging directly with these stakeholders at four national benefits conferences in June, where the company plans to discuss innovative approaches to cardiovascular disease prevention, risk assessment and cost management.

• Cardiovascular disease remains one of the most expensive health conditions in the United States.
• Cardio Diagnostics announced plans to participate in four national benefits conferences during June.
• The company has developed a suite of solutions designed to provide earlier identification of cardiovascular risk and enable more targeted interventions and preventive care.

According to the American Heart Association (“AHA”), cardiovascular disease remains one of the most expensive health conditions in the United States. Direct cardiovascular healthcare costs accounted for approximately 11% of all U.S. healthcare expenditures in 2020–2021, more than any major diagnostic…

Read More

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO

Forward Looking Statements

Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law

This contant was orignally distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Cardio Diagnostics Holdings (CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthcare Costs.